Navigation Links
WuXi PharmaTech Announces Second-Quarter 2009 Results
Date:8/11/2009

ncome (expenses), net 2,975 (2,281) * 6,368 527 * Interest income (expenses), net 144 (21) * 94 495 * Total other income (expenses), net 3,119 (2,302) * 6,462 1,022 * Income from continuing operations before income taxes 16,755 8,901 88% 30,373 25,931 17% Income tax (expenses) benefit (2,069) 1,795 * (3,952) (66) * Income from continuing operations 14,686 10,696 37% 26,421 25,865 2% Loss on discontinued operations, net (Note 1) Loss from operations of discontinued component -- (3,478) * -- (5,522) * Income tax benefit -- 1,302 * -- 2,038 * Loss on discontinued operations -- (2,176) * -- (3,484) * Net income 14,686 8,520 72% 26,421 22,381 18% Basic net earnings (loss) per ADS: Earnings from continuing operations 0.22 0.17 26% 0.39 0.42 (6%) Loss on discontinued operations- net of tax (Note 1) -- (0.03) * -- (0.06) * Net earnings per ADS 0.22 0.14 59% 0.39 0.36 9% Weighted average ADS outstanding- basic 67,944,436 662,588,246 67,469,104 62,241,856 Diluted net earnings (loss) per ADS: Earnings from continuing operations 0.20 0.15 37% 0.36 0.36 1% Loss on discontinued operations- net of tax (Note 1) -- (0.03) * -- (0.05) * Net earnings per ADS 0.20 0.12 72% 0.36 0.31 17%
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting
2. WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
3. WuXi PharmaTech Receives Award from BASF
4. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
5. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
6. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
7. WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
8. WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
9. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
10. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
11. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today ... R-Pharm, a leading Russian pharmaceutical company, to develop and ... Russian Federation , Turkey ... is a novel antibiotic for the treatment of bacterial ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company ... under simulated embryonic conditions, today announced that they have ... Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent ... is an amendment to the existing license between Histogen ...
(Date:1/14/2014)... January 14, 2014 EquitiesIQ, a leading ... (OTCQB: ALQA). Alliqua is an emerging biomedical company acquiring, ... wound care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... a seasoned management team and Board, which launched the ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility ... of Product Strategy. In this role, Michelle will work with ... guide in the development of iLab products. Her main goal ... benefit to the scientific community by offering the most advanced, ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... NASA,s Johnson Space Center,has awarded a five-year, ... Space Biomedical Research Institute, also known,as NSBRI, of ... Human,Research Program will continue biomedical research in support ... base period of the cooperative agreement began April ...
... BASEL, Switzerland and NUTLEY, N.J., Oct. 1 ... industry,s leading business and,marketing publications, selected Roche out ... the Year." This marks the first time Roche ... the company,s focus on innovation-driven,healthcare as demonstrated by ...
... ARBOR, Mich., Oct. 1 Assay Designs, Inc., a leading,provider ... translational research markets, announced two key additions to its,senior leadership ... company as Vice President, Research and ... Amgen in Thousand Oaks, CA, where he was ...
Cached Biology Technology:Med Ad News Honors Roche as 'Company of the Year' 2Med Ad News Honors Roche as 'Company of the Year' 3Assay Designs(TM) Announces Additions to the Leadership Team 2
(Date:4/24/2014)... simple and cheap way of making a high-powered lens ... microscope. , Costing less than a cent, the lenses ... countries and remote areas. , The lens fabrication technique ... National University (ANU) Research School of Engineering, who collaborated ... Medical Research to find ways to transform the lentil-sized ...
(Date:4/24/2014)... University of North Carolina at Chapel Hill have developed ... plaque that is at high risk of breaking off ... is the plaque that builds up in arteries as ... meaning that they are more likely to detach from ... , "Existing state-of-the-art technologies are capable of determining if ...
(Date:4/24/2014)... plant puts out a welcome mat to bacteria seeking to ... The study published this week in the Proceedings of ... the battle between microbe and host that researchers can exploit ... and oft-studied plant Arabidopsis puts out a molecular ... if a hostile army were unknowingly passing by a castle, ...
Breaking Biology News(10 mins):Droplet lens 2New ultrasound device may add in detecting risk for heart attack, stroke 2How a plant beckons the bacteria that will do it harm 2How a plant beckons the bacteria that will do it harm 3
... Kofi Annan shared his hope with a gathering of ... of Commitment on HIV/AIDS would have heralded a response ... "significant but insufficient". , Citing achievements in the core ... of prevention programmes, and the availability of drug therapies, ...
... account for many cases of immune deficiency, in particular ... Common Variable Immunodeficiency (CVID), report researchers in the July ... a new diagnostic test for these conditions, which make ... because of a lack of good tests. , IgA ...
... voices they hear to the number of faces they ... finding indicates that numerical perception is truly an abstract ... sense, said the researchers. The experimental approach also will ... they have a verbal capacity, understand similar abstract numerical ...
Cached Biology News:Progress on HIV/AIDS significant but insufficient 2Progress on HIV/AIDS significant but insufficient 3Progress on HIV/AIDS significant but insufficient 4Gene for immune deficiency syndromes found 2Monkeys understand numbers across senses 2
Request Info...
Rabbit polyclonal to Presenilin 1, prediluted ( Abpromise for all tested applications). entrezGeneID: 5663 SwissProtID: P49768...
... are designed for use with the ProQuest ... MaV203 contains deletions in the endogenous GAL4 ... two-hybrid systems. The strain also has leu2 ... bait and prey vectors. MaV203 contains three ...
Mouse monoclonal [CAT-1] to Chloramphenicol Acetyltransferase ( Abpromise for all tested applications)....
Biology Products: